DE2967632D1 - Use of a xanthine derivate in the manufacture of a medicament - Google Patents

Use of a xanthine derivate in the manufacture of a medicament

Info

Publication number
DE2967632D1
DE2967632D1 DE7979300516T DE2967632T DE2967632D1 DE 2967632 D1 DE2967632 D1 DE 2967632D1 DE 7979300516 T DE7979300516 T DE 7979300516T DE 2967632 T DE2967632 T DE 2967632T DE 2967632 D1 DE2967632 D1 DE 2967632D1
Authority
DE
Germany
Prior art keywords
derivate
xanthine
medicament
manufacture
xanthine derivate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE7979300516T
Other languages
German (de)
English (en)
Inventor
Joachim Ewald Goring
Peter Paul Ochlich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Wuelfing GmbH and Co KG
Original Assignee
Beecham Wuelfing GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10069529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE2967632(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Wuelfing GmbH and Co KG filed Critical Beecham Wuelfing GmbH and Co KG
Application granted granted Critical
Publication of DE2967632D1 publication Critical patent/DE2967632D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE7979300516T 1978-04-22 1979-03-29 Use of a xanthine derivate in the manufacture of a medicament Expired DE2967632D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1600878 1978-04-22

Publications (1)

Publication Number Publication Date
DE2967632D1 true DE2967632D1 (en) 1986-12-04

Family

ID=10069529

Family Applications (1)

Application Number Title Priority Date Filing Date
DE7979300516T Expired DE2967632D1 (en) 1978-04-22 1979-03-29 Use of a xanthine derivate in the manufacture of a medicament

Country Status (10)

Country Link
EP (1) EP0005015B1 (enExample)
JP (1) JPS54143527A (enExample)
AU (1) AU523136B2 (enExample)
CA (1) CA1117419A (enExample)
DE (1) DE2967632D1 (enExample)
DK (1) DK164679A (enExample)
FR (1) FR2423222A1 (enExample)
IL (1) IL57711A0 (enExample)
PH (1) PH15024A (enExample)
ZA (1) ZA791911B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59664A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
GB8501488D0 (en) * 1985-01-21 1985-02-20 Beecham Group Plc Treatment
IL106861A (en) * 1986-12-31 1997-02-18 Hoechst Roussel Pharma Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
JP2584507Y2 (ja) * 1993-05-24 1998-11-05 住友電装株式会社 電線の防水構造
AU6126098A (en) * 1997-11-28 1999-06-16 Nikolai Vasilievich Karsanov Anti-hypoxic and anti-ischemic drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2402908C2 (de) * 1974-01-22 1982-12-02 Fa. Johann A. Wülfing, 4040 Neuss 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
CH608236A5 (enExample) * 1974-01-22 1978-12-29 Wuelfing J A Fa

Also Published As

Publication number Publication date
PH15024A (en) 1982-05-13
AU4622279A (en) 1979-11-22
IL57711A0 (en) 1979-11-30
JPS54143527A (en) 1979-11-08
CA1117419A (en) 1982-02-02
EP0005015A1 (en) 1979-10-31
EP0005015B1 (en) 1986-10-29
ZA791911B (en) 1980-04-30
DK164679A (da) 1979-12-03
FR2423222B1 (enExample) 1982-07-16
FR2423222A1 (fr) 1979-11-16
AU523136B2 (en) 1982-07-15
JPH02326B2 (enExample) 1990-01-08

Similar Documents

Publication Publication Date Title
US4295567B1 (en) Medicament container
IL58209A0 (en) Medicament inhaler
DE2966630D1 (en) Apnea monitor
GR64905B (en) N2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
GB2016457B (en) Iodopropargyl derivatives their use and preparation
GB2033068B (en) Vaporiser
IL58106A0 (en) The preparation of 4-fluoro-3-phenoxy-toluene
GB2028312B (en) Xanthine tracers and their preparation
FR2423222B1 (enExample)
DE2960021D1 (en) Acyloxy-2-butenes, their preparation and their use for the preparation of 4-acetoxytiglinaldehyde
ZA793923B (en) Medicinal formulation
GB1546034A (en) Therapeutic compositions and the use thereof
JPS54141797A (en) Therapeutic drug
JPS54158418A (en) Preparing formed body
IL57507A0 (en) The preparation of 2-oximinophenylaceto-nitrile
ZA794581B (en) N 2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
JPS54154767A (en) 55arylaminoo2*22difluoroodibenzodioxol*its manufacture and its use for vermine expelling
ZA793928B (en) Medicinal formulation
JPS5572172A (en) Diastereomerr11*44chlorophenoxy**11 *11imidazolyl**3*33dimethyll22butanol*its manufacture and use as drug
JPS54160372A (en) Novel hydroxypropyllimidazole compounds* their manufacture and medical use
JPS54158417A (en) Preparing formed body
GB2028660B (en) Administration set
IL58268A0 (en) The preparation of nn-dimethylaminoacetonitrile
JPS5592397A (en) Ravidomycin and its manufacture and use
JPS54125676A (en) 11oxaa44azaa2*66disilacyclohexanes*their manufacture and use

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation